AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 20-A-02-087.01
We recommend that New York State Department of Health bill for and collect from manufacturers rebates for single-source and top-20 multiple-source…
The recommendation, in the publisher's words
We recommend that New York State Department of Health bill for and collect from manufacturers rebates for single-source and top-20 multiple-source pharmacy and physician-administered drugs and refund the estimated $7,846,147 (Federal share).
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- April 7, 2020
- Report
- New York Did Not Bill Manufacturers for Some Rebates for Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations (A-02-18-01016) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- October 16, 2024 (publisher's date)
- Potential savings
- $7,846,147 (the publisher's figure; not realised savings)
- Publisher topics
- Managed Care, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
2 more, of which 0 are open in the publisher's file.
- We recommend New York State Department of Health work with CMS to determine whether the other pharmacy and physician-administered drugs were eligible for rebates and, if so, upon receipt…HHS OIG 20-A-02-087.02 · issued Apr 7, 2020 · closed Oct 16, 2024Closed Implemented
- We recommend New York State Department of Health strengthen its internal controls to ensure that all pharmacy and physician-administered drugs eligible for rebates are invoiced.HHS OIG 20-A-02-087.03 · issued Apr 7, 2020 · closed Jul 18, 2023Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.